McKesson Corporation
MCKHealthcareNASDAQMedical Distribution
Scan Results
Daily timeframeHeadquartered within the healthcare sector, McKesson Corporation focuses on Medical Distribution services and products. McKesson Corporation provides healthcare services in the United States and internationally. With a market capitalization of $88.56B, it sits in large-cap territory. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Market Cap
$88.56B
Beta
0.35
P/E (TTM)
19.19
P/E (Fwd)
14.64
EPS (TTM)
$38.39
EPS (Fwd)
$50.32
ROE
—
ROA
5.0%
Cash
$3.98B
Total Debt
$8.79B
Free CF
$5.66B
52W Change
3.9%
Annual Financials
Cash vs Debt
The company holds $3.98B in cash, though total debt stands at $8.79B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $5.66B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROA of 5.0% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $276.71B (2023) to $403.43B (2026), reflecting a 46% increase over the period.
MCK's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. No single metric tells the full story. Reviewing MCK's risk profile alongside its fundamentals and technical indicators provides a more complete picture.